A systematic test of the relation of ASD heterogeneity to synaptic function
ASD 异质性与突触功能关系的系统测试
基本信息
- 批准号:7842915
- 负责人:
- 金额:$ 89.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAffectAutistic DisorderBiologicalBiological AssayBrainCandidate Disease GeneCell SurvivalCellsClassificationClinicalCognition DisordersCommunicationCommunitiesComplexCopy Number PolymorphismDataEffectivenessElectroporationExhibitsFundingGene DeletionGene DuplicationGene MutationGene SilencingGenerationsGenesGeneticGoalsHeritabilityHeterogeneityHippocampus (Brain)Homologous GeneImpairmentInjection of therapeutic agentLaboratoriesLibrariesMeasuresMolecularMorphologyMusMutationNeurobiologyNeuronsOpticsOther GeneticsPathogenesisPathway interactionsPatientsPhenotypePhysiologicalProcessProteinsPublicationsReagentRoleSliceSubfamily lentivirinaeSymptomsSynapsesTechniquesTestingTherapeutic InterventionTranslatingVariantVirusautism spectrum disorderbaseclinical phenotypecombinatorialdensitydesigngain of functionin uteroin vivoknock-downneuron developmentoverexpressionpublic health relevanceresponsesmall hairpin RNAsynaptic functionsynaptogenesistooltool developmentvectorweb site
项目摘要
DESCRIPTION (provided by applicant): Although autism spectrum disorders (ASDs) are highly heritable, ASDs are heterogeneous, and no single genetic cause contributes to ASDs in a large proportion of patients. Instead, heterogeneous genetic changes, including many single gene mutations and copy-number variations (CNVs) are found in ASDs. Thus, a key question is whether different genetic changes contribute to ASDs via multiple, independent, pathogenic pathways, or whether the various genetic changes in ASDs converge onto a single pathogenic pathway. Several independent mutations in genes encoding synaptic proteins, such as neurexin-1, neuroligins, and SHANK3, suggested that ASDs may generally involve an impairment of synaptic communication between neurons. However, most of the other genetic changes observed in ASDs have no known effect on synapses in fact, have no known effect on any brain function. Thus, the major goal of the present proposal is to conduct a large scale, systematic analysis of the synaptic effects of genetic changes in ASDs. The approach will be to over express (to mimic gene duplications) or knock down (to mimic gene inactivations) mRNAs corresponding to 81 ASD candidate genes, and to test the effect of these manipulations on synapses using standardized assays. Cell viability, neuronal development, synapse density and synapse function will be assessed in cultured mouse neurons using optical and electro-physiological assays that are well established in the PI's laboratories. Genes that were found to affect neuronal development, synapse formation, or synapse function in cultured neurons will be studied by the same manipulations in vivo after stereotaxic injection of lentiviruses into the mouse hippocampus, or after in utero electroporation. Changes in synapse function and plasticity will then be examined in acute slices from these mice using standard electrophysiological techniques well established in the PI's laboratories. All results from this project will be posted on a dedicated public website, and all reagents generated will be made readily available to the scientific community. The results of this project will provide a standardized reference point for the function of ASD candidate genes, and provide an initial test of the hypothesis that despite their clinical and genetic heterogenity, ASDs involve a common, if diverse, pathway acting on synaptic communication in the brain.
PUBLIC HEALTH RELEVANCE: Autism spectrum disorders are known to be clinically and genetically heterogeneous, but it is unclear whether these two types of heterogeneity are related, and how specifically the various genetic changes affect brain function. This project will address these issues by studying the changes in neuron-to-neuron communication caused by the genes associated with autism.
描述(由申请人提供):尽管自闭症谱系障碍(ASDS)是高度遗传的,但ASD是异质的,并且没有任何遗传原因在很大一部分患者中会造成ASD的贡献。取而代之的是,在ASD中发现了异质遗传变化,包括许多单个基因突变和拷贝数变化(CNV)。因此,一个关键的问题是,不同的遗传变化是否通过多个,独立的,致病的途径导致ASD,或者ASDS中的各种遗传变化是否会融合到单个致病途径上。编码突触蛋白的基因中的几个独立突变,例如Neurexin-1,Neuroligins和Shank3,表明ASD通常涉及神经元之间突触通信的损害。但是,在ASD中观察到的大多数其他遗传变化实际上对突触没有已知影响,对任何大脑功能尚无影响。因此,本提案的主要目标是对ASDS遗传变化的突触作用进行大规模的系统分析。该方法将是过度表达(模仿基因的重复)或敲低(模仿基因失活的)mRNA,与81个ASD候选基因相对应,并使用标准化测定法测试这些操纵对突触的影响。细胞活力,神经元发育,突触密度和突触功能将在PI实验室中良好确定的光学和电生物学测定法中评估在培养的小鼠神经元中。发现培养神经元中神经元发育,突触形成或突触功能的基因将通过体内的同一操作在体内进行体内进行研究,而慢病毒将慢病毒注射到小鼠海马中,或者在子宫型电穿孔中。然后,将使用PI实验室中确定的标准电生理技术在这些小鼠的急性切片中检查突触功能和可塑性的变化。该项目的所有结果都将发布在专用的公共网站上,并且生成的所有试剂将易于为科学界提供。该项目的结果将为ASD候选基因的功能提供标准化的参考点,并提供了以下假设的初步检验:尽管具有临床和遗传异质性,但ASD涉及一种对大脑突触通信作用的常见途径。
公共卫生相关性:已知自闭症谱系在临床和遗传上是异质性的,但目前尚不清楚这两种异质性是否相关,以及各种遗传变化如何影响大脑功能。该项目将通过研究与自闭症相关的基因引起的神经元间通信的变化来解决这些问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C MALENKA其他文献
ROBERT C MALENKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C MALENKA', 18)}}的其他基金
Brain-wide circuit mapping to delineate therapeutic strategies for amphetamine abuse
全脑回路图绘制以描绘苯丙胺滥用的治疗策略
- 批准号:
10494007 - 财政年份:2017
- 资助金额:
$ 89.8万 - 项目类别:
Role of postsynaptic synaptotagmins in synaptic plasticity
突触后突触结合蛋白在突触可塑性中的作用
- 批准号:
8854548 - 财政年份:2015
- 资助金额:
$ 89.8万 - 项目类别:
Cell type-specific role of Homer proteins in synaptic plasticity
荷马蛋白在突触可塑性中的细胞类型特异性作用
- 批准号:
8246070 - 财政年份:2011
- 资助金额:
$ 89.8万 - 项目类别:
Cell type-specific role of Homer proteins in synaptic plasticity
荷马蛋白在突触可塑性中的细胞类型特异性作用
- 批准号:
8339434 - 财政年份:2011
- 资助金额:
$ 89.8万 - 项目类别:
Activity-Dependent Synaptic and Circuit Plasticity
活动依赖性突触和电路可塑性
- 批准号:
7943087 - 财政年份:2009
- 资助金额:
$ 89.8万 - 项目类别:
Activity-dependent Synaptic and Circuit Plasticity
活动依赖性突触和电路可塑性
- 批准号:
9046523 - 财政年份:2009
- 资助金额:
$ 89.8万 - 项目类别:
Activity-Dependent Synaptic and Circuit Plasticity
活动依赖性突触和电路可塑性
- 批准号:
7691958 - 财政年份:2009
- 资助金额:
$ 89.8万 - 项目类别:
Activity-Dependent Synaptic and Circuit Plasticity
活动依赖性突触和电路可塑性
- 批准号:
8332321 - 财政年份:2009
- 资助金额:
$ 89.8万 - 项目类别:
Activity-dependent Synaptic and Circuit Plasticity
活动依赖性突触和电路可塑性
- 批准号:
8854546 - 财政年份:2009
- 资助金额:
$ 89.8万 - 项目类别:
Activity-Dependent Synaptic and Circuit Plasticity
活动依赖性突触和电路可塑性
- 批准号:
8529617 - 财政年份:2009
- 资助金额:
$ 89.8万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 89.8万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 89.8万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 89.8万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 89.8万 - 项目类别: